DK0623629T3 - Rensede hepainfraktioner, fremgangsmåde til fremstilling deraf samt farmaceutiske midler indeholdende dem - Google Patents

Rensede hepainfraktioner, fremgangsmåde til fremstilling deraf samt farmaceutiske midler indeholdende dem

Info

Publication number
DK0623629T3
DK0623629T3 DK94400994.3T DK94400994T DK0623629T3 DK 0623629 T3 DK0623629 T3 DK 0623629T3 DK 94400994 T DK94400994 T DK 94400994T DK 0623629 T3 DK0623629 T3 DK 0623629T3
Authority
DK
Denmark
Prior art keywords
hepain
fractions
purified
preparation
pharmaceutical agents
Prior art date
Application number
DK94400994.3T
Other languages
Danish (da)
English (en)
Inventor
Jean-Francois Branellec
Jose Espejo
Philippe Picart
Original Assignee
Choay Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9446915&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0623629(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Choay Sa filed Critical Choay Sa
Application granted granted Critical
Publication of DK0623629T3 publication Critical patent/DK0623629T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • C08B37/0078—Degradation products
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Materials Engineering (AREA)
  • Molecular Biology (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compounds Of Unknown Constitution (AREA)
DK94400994.3T 1993-05-07 1994-05-06 Rensede hepainfraktioner, fremgangsmåde til fremstilling deraf samt farmaceutiske midler indeholdende dem DK0623629T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9305534A FR2704861B1 (fr) 1993-05-07 1993-05-07 Fractions d'héparine purifiées, procédé d'obtention et compositions pharmaceutiques les contenant.

Publications (1)

Publication Number Publication Date
DK0623629T3 true DK0623629T3 (da) 1996-12-23

Family

ID=9446915

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94400994.3T DK0623629T3 (da) 1993-05-07 1994-05-06 Rensede hepainfraktioner, fremgangsmåde til fremstilling deraf samt farmaceutiske midler indeholdende dem

Country Status (26)

Country Link
US (1) US5599801A (no)
EP (1) EP0623629B1 (no)
JP (1) JP3529835B2 (no)
KR (1) KR100328095B1 (no)
CN (1) CN1066155C (no)
AT (1) ATE141618T1 (no)
AU (1) AU672291B2 (no)
BR (1) BR9401920A (no)
CA (1) CA2122930C (no)
CZ (1) CZ287889B6 (no)
DE (1) DE69400385T2 (no)
DK (1) DK0623629T3 (no)
ES (1) ES2093494T3 (no)
FI (1) FI107388B (no)
FR (1) FR2704861B1 (no)
GR (1) GR3021648T3 (no)
HK (1) HK1007432A1 (no)
HU (1) HU221595B (no)
IL (1) IL109587A (no)
MY (1) MY110862A (no)
NO (1) NO306952B1 (no)
NZ (1) NZ260460A (no)
PL (1) PL178294B1 (no)
RU (1) RU2133253C1 (no)
TW (1) TW438812B (no)
ZA (1) ZA943152B (no)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6001820A (en) * 1995-03-31 1999-12-14 Hamilton Civic Hospitals Research Development Inc. Compositions and methods for inhibiting thrombogenesis
US5763427A (en) * 1995-03-31 1998-06-09 Hamilton Civic Hospitals Research Development Inc. Compositions and methods for inhibiting thrombogenesis
US5744457A (en) * 1995-03-31 1998-04-28 Hamilton Civic Hospitals Research Development Inc. Compositions and methods for inhibiting thrombogenesis
US5980865A (en) * 1995-08-18 1999-11-09 Baker Norton Pharmaceuticals, Inc. Method for treating late phase allergic reactions and inflammatory diseases
CA2235223A1 (en) 1995-10-30 1997-05-09 Massachusetts Institute Of Technology Rationally designed polysaccharide lyases derived from heparinase i
US5767269A (en) * 1996-10-01 1998-06-16 Hamilton Civic Hospitals Research Development Inc. Processes for the preparation of low-affinity, low molecular weight heparins useful as antithrombotics
IT1290814B1 (it) * 1997-03-24 1998-12-11 Istituto Scient Di Chimica E B Glicosaminoglicani aventi elevata attivita' antitrombotica
JP2003527822A (ja) * 1998-08-27 2003-09-24 マサチューセッツ インスティテュート オブ テクノロジー ヘパリナーゼｉおよびｉｉ由来の合理的に設計されたヘパリナーゼ
US7056504B1 (en) 1998-08-27 2006-06-06 Massachusetts Institute Of Technology Rationally designed heparinases derived from heparinase I and II
CA2643162C (en) * 1999-04-23 2018-01-02 Massachusetts Institute Of Technology Polymer identification, compositional analysis and sequencing, based on property comparison
CA2402160C (en) * 2000-03-08 2012-02-14 Massachusetts Institute Of Technology Heparinase iii and uses thereof
US8227449B2 (en) * 2000-03-30 2012-07-24 Glycores 2000 S.R.L. Glycosaminoglycans derived from K5 polysaccharide having high anticoagulant and antithrombotic activities and process for their preparation
IT1318432B1 (it) * 2000-03-30 2003-08-25 Inalco Spa Glicosaminoglicani derivati dal polisaccaride k5 aventi elevataattivita' anticoagulante ed antitrombotica e processo per la loro
ATE426805T1 (de) * 2000-09-12 2009-04-15 Massachusetts Inst Technology Verfahren und produkte, die mit niedermolekularem heparin assoziiert sind
CA2423469A1 (en) * 2000-10-18 2002-04-25 Massachusetts Institute Of Technology Methods and products related to pulmonary delivery of polysaccharides
US20050027117A1 (en) * 2000-12-18 2005-02-03 Pasqua Oreste Anticoagulant and antithrombotic LMW-glycosaminoglycans derived from K5 polysaccharide and process for their preparation
JP2002293804A (ja) * 2001-03-28 2002-10-09 Itoham Foods Inc 低分子量ヘパリンの製造法
EP2402753A1 (en) 2002-03-11 2012-01-04 Momenta Pharmaceuticals, Inc. Analysis of sulfated polysaccharides
EP1582531A1 (en) 2004-03-24 2005-10-05 Aventis Pharma S.A. Process for oxidizing unfractionated heparins and detecting presence or absence of glycoserine in heparin and heparin products
ITMO20040199A1 (it) * 2004-07-29 2004-10-29 Biofer Spa Procedimento per la purificazione da gruppi e n no rsidui di eparine a basso peso molecolare ottentite tramite nitrosazione.
JP2006291028A (ja) * 2005-04-11 2006-10-26 Q P Corp 低分子ヘパリンまたはその塩、ならびにその製造方法
EP1792621B1 (en) 2005-11-30 2012-04-04 Istituto di Ricerche Chimiche e Biochimiche "G. Ronzoni" Orally administrable heparin derivatives
US9139876B1 (en) 2007-05-03 2015-09-22 Momenta Pharmacueticals, Inc. Method of analyzing a preparation of a low molecular weight heparin
ES2817779T3 (es) * 2010-01-19 2021-04-08 Momenta Pharmaceuticals Inc Evaluación de preparaciones de heparina
CA2811186C (en) * 2010-09-14 2018-12-04 Michio Muguruma High purity heparin and production method therefor
WO2012115952A1 (en) 2011-02-21 2012-08-30 Momenta Pharmaceuticals, Inc. Evaluating heparin preparations
CN102633905B (zh) * 2011-04-11 2014-10-08 南通天龙畜产品有限公司 一种肝素钠中不被亚硝酸降解且在肝素钠保留时间附近出峰的物质的去除方法
CN104045744B (zh) * 2014-06-26 2016-01-06 常州千红生化制药股份有限公司 达肝素钠的制备方法
CN104098716B (zh) * 2014-07-16 2015-04-22 南京健友生化制药股份有限公司 一种达肝素钠精品的生产方法
US10688249B2 (en) * 2015-06-11 2020-06-23 Virchow Biotech Pvt. Ltd. Multiple dose pharmaceutical compositions containing heparin and/or heparin-like compounds and devices and methods for delivering the same
CN105294885A (zh) * 2015-11-23 2016-02-03 山东大学 一种新来源亚硝酸降解低分子肝素的制备方法
EP3740513B1 (en) * 2018-02-14 2022-06-22 Biological E Limited Improved process for the preparation of dalteparin sodium
RU186728U1 (ru) * 2018-10-19 2019-01-30 Федеральное государственное бюджетное образовательное учреждение высшего образования "МИРЭА - Российский технологический университет" Лабораторное устройство для отмывки порошковых продуктов химических реакций от посторонних примесей
WO2022015794A1 (en) 2020-07-14 2022-01-20 Optimvia, Llc Methods for synthesizing non-anticoagulant heparan sulfate
CN114616340A (zh) 2019-07-09 2022-06-10 奥普蒂姆维亚有限公司 合成抗凝血多糖的方法
CN110845641A (zh) * 2019-11-07 2020-02-28 中国药科大学 一种肝素寡糖及其在制备抗血管生成药物中的应用
CN110787489A (zh) * 2019-11-20 2020-02-14 江苏千牧生物科技股份有限公司 一种肝素钠加工使用的分离装置及加工的工艺
CN115304688A (zh) * 2022-08-25 2022-11-08 湖北亿诺瑞生物制药有限公司 一种达肝素钠的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2478646A2 (fr) * 1980-03-20 1981-09-25 Choay Sa Composition mucopolysaccharidique ayant une activite regulatrice de la coagulation, medicament la contenant et procede pour l'obtenir
US4438261A (en) * 1980-05-19 1984-03-20 Riker Laboratories, Inc. Anticoagulant substance
US4351938A (en) * 1980-05-19 1982-09-28 Riker Laboratories, Inc. Anticoagulant substance
CA1171375A (en) * 1980-09-15 1984-07-24 Ulf P.F. Lindahl Oligosaccharides having selective anticoagulation activity
FR2503714B1 (fr) * 1981-04-10 1986-11-21 Choay Sa Procede d'obtention de mucopolysaccharides biologiquement actifs, de purete elevee, par depolymerisation de l'heparine
US5094815A (en) * 1988-05-18 1992-03-10 Cornell Research Foundation, Inc. Photolytic interface for HPLC-chemiluminescence detection of non volatile N-nitroso compounds
US5032679A (en) * 1988-12-15 1991-07-16 Glycomed, Inc. Heparin fragments as inhibitors of smooth muscle cell proliferation
IT1243300B (it) * 1990-12-20 1994-05-26 Fidia Spa Derivati dell'eparina
US5385937A (en) * 1991-04-10 1995-01-31 Brigham & Women's Hospital Nitrosation of homocysteine as a method for treating homocysteinemia

Also Published As

Publication number Publication date
HK1007432A1 (en) 1999-04-09
MY110862A (en) 1999-05-31
IL109587A (en) 1997-04-15
TW438812B (en) 2001-06-07
NO941686D0 (no) 1994-05-06
HU9401446D0 (en) 1994-08-29
ES2093494T3 (es) 1996-12-16
AU672291B2 (en) 1996-09-26
CN1096034A (zh) 1994-12-07
IL109587A0 (en) 1994-08-26
CZ287889B6 (cs) 2001-03-14
EP0623629A1 (fr) 1994-11-09
FR2704861A1 (fr) 1994-11-10
HUT70553A (en) 1995-10-30
EP0623629B1 (fr) 1996-08-21
ZA943152B (en) 1995-01-09
FI942095A0 (fi) 1994-05-06
CA2122930A1 (en) 1994-11-08
ATE141618T1 (de) 1996-09-15
RU2133253C1 (ru) 1999-07-20
RU94015595A (ru) 1996-09-27
CA2122930C (en) 2000-10-24
PL178294B1 (pl) 2000-04-28
US5599801A (en) 1997-02-04
JP3529835B2 (ja) 2004-05-24
JPH07126302A (ja) 1995-05-16
AU6191294A (en) 1994-11-10
DE69400385D1 (de) 1996-09-26
GR3021648T3 (en) 1997-02-28
CZ113294A3 (en) 1994-12-15
NO306952B1 (no) 2000-01-17
CN1066155C (zh) 2001-05-23
NO941686L (no) 1994-11-08
BR9401920A (pt) 1994-11-29
DE69400385T2 (de) 1996-12-19
FR2704861B1 (fr) 1995-07-28
NZ260460A (en) 1996-02-27
FI942095A (fi) 1994-11-08
KR100328095B1 (ko) 2002-06-20
HU221595B (hu) 2002-11-28
FI107388B (fi) 2001-07-31

Similar Documents

Publication Publication Date Title
DK0623629T3 (da) Rensede hepainfraktioner, fremgangsmåde til fremstilling deraf samt farmaceutiske midler indeholdende dem
DE69027440T2 (de) Bizyklische pyrimidinderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung
ATE187167T1 (de) Amido-3-pyrazol-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen
GR3004582T3 (no)
DE68908374D1 (de) Propenonoximether, verfahren zu dessen herstellung sowie diese enthaltende arzneinmittel.
DE69203838D1 (de) Sauerstoff-Absorber und Verfahren zu dessen Herstellung.
IT8468235A1 (it) Nuovi derivati di 3-benzilidene-canfora, procedimento per la loro preparazione e loro impiego come agenti protettivi contro i raggi UV e come farmaci.
IT1269961B (it) Processo per la produzione di derivati orto-isopropil-fenoli
NO975466L (no) Amorf, farget plate av en krystalliserbar termoplast
BR9103481A (pt) Composto,estereoisomero,composicao farmaceutica e processo para preparar um composto
FR2709753B1 (fr) Nitrates organiques, leur procédé de préparation et leur application comme médicaments.
ATA252892A (de) Benzofuranylimidazolderivate, verfahren zu deren herstellung und sie enthaltende therapeutische zusammensetzungen
ATE128977T1 (de) 1,4-benzodioxanderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen.
IT8921578A0 (it) Derivati imidazolici 1,5 disostituiti e processo per la loro preparazione.
ATE141614T1 (de) Neue peptidderivate im prozess von zelladhäsion wirksam, verfahren zur deren herstellung und pharmazeutische zusammensetzungen die sie enthalten
AU3555393A (en) Process for the purification of 1,1-dichloro-1-fluoroethane
ITMI913034A1 (it) Metodo per il trattamento chimico di tutte le sostanze organiche con un prodotto atto ad eliminare in modo rapido gli odori da esse emanati e per l'impiego del composto risultante come fertilizzante
LV5780B4 (lv) Pretkonvulsiji triazolÚ4,5-c¾piridina atvasinajumi
IT8921601A0 (it) Derivati 4 amminofenilici cicloalchil sostituiti e processo per la loro preparazione.
ATE105284T1 (de) Pyridazin-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen.